secwatch.observer — SEC 8-K summary
======================================

Issuer:     NOVAVAX INC (NVAX)
CIK:        0001000694
Form:       8-K
Filed at:   2022-12-19T23:59:59+00:00
Accession:  0001104659-22-128263
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Novavax launches $150M convertible notes (5% due 2027) and 6.5M share offering at $10
--------------------------------------------------------------------------------

- Common stock offering of 6.5M shares at $10.00; underwriters fully exercised option for 975k additional shares.
- Convertible notes offering upsized to $150M aggregate principal; initial purchasers granted option for $25.25M more.
- Notes bear 5.00% interest, mature Dec 15, 2027; initial conversion price $12.50 per share (25% premium to stock offering price).
- Both offerings expected to close Dec 20, 2022; neither is contingent on the other.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1000694/000110465922128263/0001104659-22-128263-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1000694/000110465922128263/tm2232888d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-128263

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer